<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>LLM enhanced graph inference for long-term disease progression modelling - Health AI Hub</title>
    <meta name="description" content="This paper introduces a novel framework that leverages Large Language Models (LLMs) to enhance graph inference for long-term disease progression modeling, speci">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>LLM enhanced graph inference for long-term disease progression modelling</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.10890v1" target="_blank">2511.10890v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-14
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Tiantian He, An Zhao, Elinor Thompson, Anna Schroder, Ahmed Abdulaal, Frederik Barkhof, Daniel C. Alexander
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.AI, stat.ML
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.10890v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.10890v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a novel framework that leverages Large Language Models (LLMs) to enhance graph inference for long-term disease progression modeling, specifically in neurodegenerative diseases like Alzheimer's Disease. By using LLMs as expert guides to synthesize multi-modal relationships, the method simultaneously optimizes individual disease trajectories and learns a biologically-constrained graph structure, leading to superior prediction accuracy and interpretability.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Accurately modeling long-term disease progression is critical for understanding the underlying mechanisms of neurodegenerative diseases, developing effective therapies, predicting patient trajectories, and improving clinical trial design.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The research applies Large Language Models (LLMs) to enhance graph inference for modeling long-term disease progression in neurodegenerative diseases like Alzheimer's. LLMs act as 'expert guides' to incorporate biological constraints and multi-modal relationships, improving the accuracy and interpretability of disease trajectory predictions from longitudinal patient and imaging data.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Current disease progression models for neurodegenerative diseases oversimplify brain connectivity by assuming a single-modality connectome, leading to inaccurate long-term predictions.</li>
                    
                    <li>Purely data-driven approaches for learning disease propagation graphs face identifiability issues due to lack of proper constraints.</li>
                    
                    <li>The proposed framework uses Large Language Models (LLMs) as 'expert guides' to synthesize multi-modal biological relationships and incorporate diverse disease-driving mechanisms.</li>
                    
                    <li>The method simultaneously optimizes two key aspects: constructing long-term disease trajectories from irregularly sampled longitudinal patient data and learning a biologically-constrained, identifiable graph structure of inter-regional interactions.</li>
                    
                    <li>The approach was demonstrated using tau-PET imaging data from an Alzheimer's Disease (AD) cohort.</li>
                    
                    <li>Results indicate superior prediction accuracy and enhanced interpretability compared to traditional disease progression modeling approaches.</li>
                    
                    <li>The framework reveals additional disease-driving factors beyond those captured by conventional brain connectivity measures, providing a more comprehensive understanding of pathology spread.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The core methodology involves a novel framework that integrates Large Language Models (LLMs) to provide expert biological guidance for graph inference. This framework simultaneously optimizes the construction of individual-level long-term disease trajectories from irregularly sampled longitudinal patient data and learns a biologically-constrained graph structure representing interactions among brain regions. LLMs synthesize multi-modal biological relationships and diverse disease-driving mechanisms to enhance model identifiability and capture complex interactions. The method was validated using tau-PET imaging data from an Alzheimer's disease cohort.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The study demonstrates that the LLM-enhanced graph inference framework achieves superior prediction accuracy for long-term disease progression in Alzheimer's Disease. It provides improved interpretability of the underlying disease mechanisms and reveals additional, previously unconsidered, disease-driving factors beyond conventional connectivity measures, offering a more nuanced understanding of pathology propagation.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This framework has the potential to significantly improve the accuracy of prognostic predictions for patients with neurodegenerative diseases like AD, facilitating more precise patient stratification for clinical trials and potentially enabling personalized treatment strategies. By identifying novel disease-driving factors, it could also guide the development of new diagnostic biomarkers and therapeutic targets for intervention.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly mention specific limitations of the proposed framework.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention future research directions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Neuroscience</span>
                    
                    <span class="tag">Diagnostic Imaging</span>
                    
                    <span class="tag">Computational Biology</span>
                    
                    <span class="tag">Geriatrics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Large Language Models</span>
                    
                    <span class="tag tag-keyword">Disease Progression</span>
                    
                    <span class="tag tag-keyword">Neurodegenerative Disease</span>
                    
                    <span class="tag tag-keyword">Alzheimer's Disease</span>
                    
                    <span class="tag tag-keyword">Graph Inference</span>
                    
                    <span class="tag tag-keyword">Biomarker Interactions</span>
                    
                    <span class="tag tag-keyword">Tau-PET</span>
                    
                    <span class="tag tag-keyword">Brain Connectivity</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Understanding the interactions between biomarkers among brain regions during neurodegenerative disease is essential for unravelling the mechanisms underlying disease progression. For example, pathophysiological models of Alzheimer's Disease (AD) typically describe how variables, such as regional levels of toxic proteins, interact spatiotemporally within a dynamical system driven by an underlying biological substrate, often based on brain connectivity. However, current methods grossly oversimplify the complex relationship between brain connectivity by assuming a single-modality brain connectome as the disease-spreading substrate. This leads to inaccurate predictions of pathology spread, especially during the long-term progression period. Meanhwile, other methods of learning such a graph in a purely data-driven way face the identifiability issue due to lack of proper constraint. We thus present a novel framework that uses Large Language Models (LLMs) as expert guides on the interaction of regional variables to enhance learning of disease progression from irregularly sampled longitudinal patient data. By leveraging LLMs' ability to synthesize multi-modal relationships and incorporate diverse disease-driving mechanisms, our method simultaneously optimizes 1) the construction of long-term disease trajectories from individual-level observations and 2) the biologically-constrained graph structure that captures interactions among brain regions with better identifiability. We demonstrate the new approach by estimating the pathology propagation using tau-PET imaging data from an Alzheimer's disease cohort. The new framework demonstrates superior prediction accuracy and interpretability compared to traditional approaches while revealing additional disease-driving factors beyond conventional connectivity measures.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>